| 000 | 01547 a2200433 4500 | ||
|---|---|---|---|
| 005 | 20250518014249.0 | ||
| 264 | 0 | _c20190408 | |
| 008 | 201904s 0 0 eng d | ||
| 022 | _a2314-6141 | ||
| 024 | 7 |
_a10.1155/2018/2785696 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aCancelli, F | |
| 245 | 0 | 0 |
_aRole of Double-Carbapenem Regimen in the Treatment of Infections due to Carbapenemase Producing Carbapenem-Resistant _h[electronic resource] |
| 260 |
_bBioMed research international _c2018 |
||
| 300 |
_a2785696 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Observational Study | ||
| 650 | 0 | 4 |
_aAnti-Bacterial Agents _xtherapeutic use |
| 650 | 0 | 4 |
_aBacteremia _xdrug therapy |
| 650 | 0 | 4 |
_aBacterial Proteins _xmetabolism |
| 650 | 0 | 4 |
_aCarbapenem-Resistant Enterobacteriaceae _xdrug effects |
| 650 | 0 | 4 |
_aCarbapenems _xtherapeutic use |
| 650 | 0 | 4 |
_aEnterobacteriaceae Infections _xdrug therapy |
| 650 | 0 | 4 |
_aErtapenem _xtherapeutic use |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aMeropenem _xtherapeutic use |
| 650 | 0 | 4 |
_aMicrobial Sensitivity Tests _xmethods |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aRetrospective Studies |
| 650 | 0 | 4 |
_abeta-Lactamases _xmetabolism |
| 700 | 1 | _aOliva, A | |
| 700 | 1 | _aDe Angelis, M | |
| 700 | 1 | _aMascellino, M T | |
| 700 | 1 | _aMastroianni, C M | |
| 700 | 1 | _aVullo, V | |
| 773 | 0 |
_tBioMed research international _gvol. 2018 _gp. 2785696 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1155/2018/2785696 _zAvailable from publisher's website |
| 999 |
_c29194238 _d29194238 |
||